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Abstract
Ascorbate is a vital reductant/free radical scavenger in the CNS, whose content defines – to a large
extent - the redox status and the antioxidant reserves. Quick, reliable and specific methods for its
measurement in brain samples are highly desirable. We have developed a new high-throughput
screening assay for measurements of ascorbate using a fluorescence plate-reader. This assay is
based on a direct reaction of ascorbate with a nitroxide radical conjugated with a fluorogenic
acridine moiety, 4-((9-acridinecarbonyl)-amino)-2,2,6,6-tetramethylpiperidine-1-oxyl radical (AC-
TEMPO), yielding fluorescent hydroxylamine product (AC-TEMPO-H). The reaction was
monitored over time using fluorescence and electron spin resonance techniques. The appearance
of fluorescent AC-TEMPO-H was linear within the range of 3.75–75 μM AscH- in the sample
(0.5–10 μM AscH- in the well). Assay was validated with high performance liquid
chromatography method. The concentration of ascorbate in murine tissue samples, including brain
samples after traumatic brain injury and hemorrhagic shock, was measured.
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Introduction
Ascorbate (vitamin C) is a vital reductant/free radical scavenger in the brain, cerebrospinal
fluid and plasma, whose content defines - to a large extent - the redox status and antioxidant
reserves of tissues and biofluids. Additionally, ascorbate acts an important cofactor – one-
electron reductant – in the process of norepinephrine biosynthesis by copper-containing
dopamine beta hyroxylase (DBH) (Diliberto and Allen, 1981). As a reductant, it can also
participate in regulation of activity of heme-peroxidases. Further, the role of ascorbate as a
physiologically important donor of electrons may be essential for the recycling of vitamin E
© 2011 Elsevier B.V. All rights reserved
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
J Neurosci Methods. Author manuscript; available in PMC 2012 September 30.
Published in final edited form as:













from its phenoxyl radical hence regulation of lipid peroxidation (reviewed in (Bors and
Buettner, 1997; Diliberto et al., 1991; Harrison and May, 2009)). Ascorbate is actively
transported into both the brain and neurons against a concentration gradient. The high
concentrations of ascorbate in cerebrospinal fluid (200–400 μM) and brain (2–10 mM),
relative to plasma (in the range of 60–100 μM) (Harrison and May, 2009), emphasize its
importance in the central nervous system. Many disease states such as ischemic or traumatic
brain injury and radiation exposure have been shown to deplete cellular ascorbate, an effect
significantly contributing to propagation of neuronal cell damage (Ates et al., 2007; Bayir et
al., 2002; Borisenko et al., 2004; Bors and Buettner, 1997; Exo et al., 2009; Viant et al.,
2005). Given the high importance of ascorbate in disease and its potential to be used as a
biomarker of oxidative stress, quick, reliable and specific methods for its measurement are
highly desirable. Different spectroscopic (including electron paramagnetic resonance (EPR)
spectroscopy) and chromatographic assays have been developed to monitor ascorbate levels
in tissues. They vary in sensitivity, speed, substrate specificity and other parameters (Bors
and Buettner, 1997; Vislisel et al., 2007; Washko et al., 1992). High performance liquid
chromatography (HPLC) has been thought to be the most sensitive and specific method for
the assessments of ascorbate, but it is the most time-consuming method.
Recently Buettner's group described a sensitive and inexpensive assay for ascorbate
measurements using a plate reader (Vislisel et al., 2007). This method is based on oxidation
of AscH− by a nitroxide radical, 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO), followed
by a fluorogenic reaction with o-phenylenediamine. While this protocol represents a useful
approach, we have set up a goal to develop a more sensitive and simplified high-throughput
assay for measuring ascorbate in biological samples, particularly in the brain samples. Our
assay is based on direct reaction of ascorbate with a nitroxide radical conjugated with a
fluorogenic acridine moiety, 4-((9-acridinecarbonyl)-amino)-2,2,6,6-
tetramethylpiperidine-1-oxyl radical (AC-TEMPO), yielding fluorescent hydroxylamine
product (AC-TEMPO-H). Simplicity, specificity, a wide range of measured AscH− and
stability of the assay allows high throughput biochemical testing using a 96 well plate
format and a fluorescence plate reader. We demonstrate the utility of the protocol for the
analysis of ascorbate content in murine tissues, including brain samples from rats subjected




L-Ascorbic acid (AA), sodium phosphate dibasic, sodium phosphate monobasic, sodium
hydroxide, diethylenetriaminepentaacetic acid (DTPA), dimethyl sulfoxide (DMSO),
metaphosphoric acid (MPA), bovine serum albumin, urea, ThioGlo-1, glutathione
peroxidase and ascorbate oxidase (AO) were all purchased from Sigma Aldrich (St. Louis,
MO). 4-((9-acridinecarbonyl)-amino)-2,2,6,6-tetramethylpiperidine-1-oxyl radical (AC-
TEMPO) was purchased from Invitrogen (Carlsbad, CA).
Solution preparation
A stock solution of ascorbic acid (AA, 10 mM) was prepared fresh daily using 50 mM
sodium phosphate buffer with 100μM DPTA, (pH=7.4) and diluted appropriately to achieve
concentrations of the standards (3.75–75 μM). AC-TEMPO was diluted to a stock
concentration of 10mM in DMSO, divided into aliquots and stored in amber colored tubes at
−80°C until use. A working solution of AC-TEMPO was prepared for each experiment by
diluting the stock solution in phosphate buffer.
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Tissue samples were homogenized using a Tissue Tearor (BioCold Scientific, Fenton MO)
in a buffer (tissue weight to volume ratio of 1:20) consisting of sodium chloride (0.1 mol/L
final concentration), Tris-chloride (0.01 mol/L final concentration), and Triton X (1%). The
homogenates were centrifuged at 1000 g for 10 minutes. The supernatants were then divided
into aliquots for measurement of protein, ascorbate and GSH. Metaphosphoric acid (MPA)
was added to the aliquot that will be used for ascorbate measurements, such that the final
concentration was 5% (v/v) to stabilize ascorbate (Bradley et al., 1973; Comstock et al.,
1995) and samples were stored at −80°C until use. At the time of the measurement, the
samples were thawed on ice and vortexed for 10 sec every 2 min at least 5 times. Following
vortexing the samples were centrifuged at 12,000g for 5 min at 4°C. The supernatant was
collected into a microcentrifuge tube and the pH was adjusted to 7.0 using 10M NaOH
individually in each sample using pH paper. The volume of base required for the adjustment
was recorded.
Fluorescence spectroscopy
For measurements of AC-TEMPO fluorescence, a Shimadzu spectrofluorimeter RF-5301PC
set at an excitation wavelength 361 nm, an excitation slit of 3 nm, and an emission slit of 3
nm was used. Time courses of fluorescence intensity were detected using an emission
wavelength 440 nm.
Plate reader assay
Each sample was divided into two aliquots, each containing 0.1–0.6 mg/ml protein. To
ensure the selectivity of the assay towards ascorbate one of the aliquots (50 μL) was treated
with 1 U of ascorbate oxidase (AO) for 40 min at room temperature, the other aliquot was
set aside on ice. When all samples were ready, they (20 μl) were transferred onto 96-well
plate along with ascorbate standards (0–1.5 nmols). After this, 130 μl AC-TEMPO stock
aliquotes (23.1 μM in phosphate buffer) were added immediately using a multi-channel
pipette to each well and samples were incubated for 40 min at room temperature in the dark
and analyzed reader (PerkinElmer Life Sciences, Boston, MA). Fluorescence was measured
using a 390±15 nm filter for excitation and 460±35 nm filter for emission. Fluorescence
readings from AO-treated sample were subtracted from non-treated and normalized to
protein (corrected for prior dilutions with MPA and NaOH). The precision of the proposed
method was tested at two levels: 30 and 45 μM ascorbate (20 μL was taken each time for
analysis); each run in triplicate with single or up to three independent runs per day over 14
days.
Electron paramagnetic resonance spectroscopy
Electron paramagnetic resonance (EPR) measurements were performed on a JEOL RE1X
spectrometer at room temperature with 100 kHz modulation (JEOL, Kyoto, Japan) in gas
permeable Teflon tubings (0.8 mm internal diameter, 0.013 mm thickness) obtained from
Alpha Wire Corporation (Elizabeth, NJ). The tubing was filled with 60 μl of sample, folded
twice, and placed in an open 3.0 mm internal diameter EPR quartz tube. AC-TEMPO
spectra were recorded under the following conditions: 3357 G, center field; 25 G, sweep
width; 0.5 G, field modulation; 10 mW, microwave power; 0.1 s, time constant; 1 min, time
scan. EPR spectra of ascorbate radicals were recorded at 3350 G, center field; 50 G, sweep
width; 10 mW, microwave power; 0.5 G, field modulation; 103, receiver gain; 0.1 s, time
constant; 1 min, scan time. Simulation of TEMPO and ascrobyl radical spectra was
performed using WinSim software (NIESH).
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High performance liquid chromatography assay of ascorbate
Samples, prepared the same way as those for the plate reader assay, were used for high
performance liquid chromatography (HPLC) measurements. A ZORBAX Eclipse XDBC18
column (5-μm particle size, 4.6×150 mm Agilent Technologies, Palo Alto, CA, USA) and a
mobile phase of 1:24 methanol–water adjusted to pH 3.0 by acetic acid at a flow rate of 1.0
ml/min were used. A Shimadzu LC-10A HPLC system was used with an LC-600 pump and
SPD-10A UV detector (Shimadzu, Kyoto, Japan) at 264 nm. Under these conditions, the
retention time for ascorbate was 2.0 min (Kagan et al., 1994; Bayir et al., 2002).
Glutathione
Glutathione (GSH) was determined using ThioGlo-1, a maleimide reagent (Sigma-Aldrich,
St. Louis, MO), which produces a highly fluorescent adduct upon its reaction with
sulfhydryls (SH) groups. Content of total low-molecular-weight thiols was estimated by an
immediate fluorescence response registered upon addition of ThioGlo-1 to tissue
homogenate (10–35 μg of protein). An aliquot of the same sample was treated with
glutathione (GSH) peroxidase (1 U) and cumene hydroperoxide (100 μmol/L) for 30 min. A
fluorescence measurement system, CytoFluor 2350 (Millipore, Bedford, MA), was used for
the assay using excitation filter A (360 ± 40 nm) and emission filter B (530 ± 25 nm). The
difference between the fluorescence response of the original sample and the GSH
peroxidase-treated sample corresponds to the amount of reduced GSH.
Animal experiment
The Institutional Animal Care and Use Committee of the University of Pittsburgh School of
Medicine approved this study. Male C57/BL6 mice (Jackson Laboratories, Bar Harbor,
ME), 12–15 weeks of age and weighing 22–29 grams, were housed under controlled
environmental conditions and allowed ad libitum food and water until the study began.
Controlled cortical impact (CCI) and HS + CCI were performed as described earlier (Exo et
al., 2009). Briefly, a mild CCI was performed with a pneumatic impactor (Bimba, Monee,
IL) with a 3-mm flat-tip impounder that was deployed at a velocity of 5 m/sec and a depth of
1 mm. Brain temperature was maintained at 38±0.5° C throughout the experiment. To
achieve HS, 2ml/100g of blood was removed from femoral venous catheter. This
hemorrhage volume resulted in a decrease in mean arterial blood pressure to 35–40 mmHg.
Mice remained in the HS phase for 90 min. After the HS phase, the mice were randomized
to one of two treatment groups, including resuscitation with Hextend (Hospira, Inc., Lake
Forest, IL) or polynitroxylated albumin (PNA, SynZyme Technologies, Irvine, CA)
targeting a mean arterial pressure (MAP) of >50 mm Hg. In separate studies, adult male rats
weighing 350–400 grams were utilized for comparative analysis of ascorbate levels
measured using HPLC assay and AC-TEMPO method in rat tissues.
Data analysis
Data are expressed as means ± SD. Changes in variables for different assays were analyzed
by either Student's t test (single comparisons) or one-way ANOVA for multiple
comparisons. Differences among means were considered to be significant at p <0.05.
Results and discussion
EPR was employed as an independent supportive method to prove the underlying
mechanism of the assay. In the dual nitroxide-fluorophore probe, 4-((9-acridinecarbonyl)-
amino)-2,2,6,6-tetramethylpiperidine-1-oxyl radical (AC-TEMPO), the paramagnetic radical
nitroxide moiety suppresses the fluorescence of the chromophore (acridine). In the absence
of ascorbate, AC-TEMPO displayed a characteristic triplet ESR spectrum with g = 2 and
superfine splitting constant (aN) of 16 G (Fig. 1A, insert). Upon addition AscH−to AC-
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TEMPO, the superposition of two radicals: Asc• and TEMPO• was observed (Fig. 1B insert,
red - simulated spectra). The reaction of ascorbate with TEMPO leads to the reduction of
latter yielding ESR silent hydroxylamine-TEMPO (TEMPOH). The reaction rate of AscH−
with AC-TEMPO measured experimentally by disappearance of nitroxide triplet signal was
3.1 M−1s−1 which is in agreement with published data (Vislisel et al., 2007). No
fluorescence was detected from AC-TEMPO in the absence of ascorbate (Fig. 1C, D). The
fluorescence signal was detected when the nitroxide was reduced to diamagnetic
hydroxylamine (AC-TEMPOH) by addition of ascorbate (Fig. 1C, D) or sodium dithionite
(data not shown). The magnitude of fluorescence intensity was proportional to the
concentration of AscH− in the sample (Fig. 1C, D). Simultaneous ESR measurements also
showed that disappearance of the initial characteristic triplet of ACTEMPO (Fig. 1A) was
proportional to AscH− added in the sample over time (Fig. 1A–B). Under our experimental
conditions (20–50 μM AC-TEMPO and AscH− < AC-TEMPO), accumulation of
fluorogenic AC-TEMPO-H reached saturation at 40 min (Fig. 1C); the saturation occurred
faster at lower ascorbate concentrations. At this time, the dependence of fluorescence vs
AscH− was linear (Fig. 1D).
We also tested whether sample preparation procedure affects accuracy of the method.
Freshly prepared ascorbate standards and the ones prepared the same way as the tissue
samples were used for calibration (Fig. 1E). Two calibration curves were identical. After
optimization of the reaction conditions, the maximal sensitivity - the lowest detectable level
of AscH− of 75 pmol/well or 3.75 μM in sample - was achieved at an ACTEMPO
concentration of 20 μM.
Clinical and Laboratory Standards Institute (CLSI) document EP15-A2 (EP15-A2, 2006)
was used as a guide for determining the precision of the proposed method. We used a
spreadsheet for assisting with the calculations as described by D. Chester in The Clinical
Biochemist Reviews (available from the Australian Association of Clinical Biochemists
web-site (Chester, 2008)). The precision of the proposed method was tested at two levels: 30
and 45 μM ascorbate. The within-run imprecision of proposed method was in the range of
2.6%; the total imprecision was ~7.6% (Table 3).
To better characterize fluorescence features of the chromophore, we employed fluorescence
spectroscopy in a wide range (370–620 nm) as well as different pH (pH=2.9 – 12.1, Fig. 1F),
ionic strengths, incubation time and confirmed the typical spectra with excitation and
emission maxima corresponding to those published in the literature (Soh et al., 2001). Based
on this detailed information, the fluorescence plate reader parameters were setup.
To test the most probable sources of interference, we examined the effects of several
physiologically relevant reductants with ascorbate determinations using ACTEMPO. These
results are shown in Table 2 as rates of AC-TEMPO reduction (expressed as pmols per
minute) by ascorbate alone or by ascorbate in the presence of GSH, cysteine, dopamine, urea
and bovine serum albumin. Additionally, typical examples of time-course of accumulation
of fluorescent AC-TEMPOH upon reaction with ascorbate in the presence of several
concentrations of dopamine are shown in Fig. 1G. Our results showed that these compounds
in concentrations exceeding those present in our samples did not affect AC-TEMPO-based
ascorbate determinations (Table 2). High concentrations of GSH (5 mM) lead to a 15%
increase in effective rate of ascorbate oxidation. Addition of BSA accelerated reaction rate,
probably due to absorption of both ascorbate and fluorescent probe to BSA (Lozinsky et al.,
2001). Further, to ensure specificity of the response, we chose to employ treatment of the
samples with ascorbate oxidase - to completely and selectively remove ascorbate from them
- and then subtracted these readings from non-treated samples
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HPLC method was used as a reference method to measure ascorbate in rat brain liver and
lung (Fig. 1I). The range of measured Asc was 2–45 nmol/mg protein. As presented in Table
1, the variations between these two methods were within 15%. To determine the predictive
capacity and accuracy of the measurement with AC-TEMPO, tissue samples were spiked
with a known amount of purified ascorbate. Briefly, samples were prepared as described and
following pH adjustment a known quantity of ascorbate was added to the sample. The
spiked samples were processed exactly the same as non-spiked samples. The predicted
values were within 10% of error.
Finally, we utilized this method for analysis of ascorbate in mouse brain after TBI (mild CCI
or CCI plus HS) followed by fluid resuscitation with Hextend® or PNA targeting a mean
arterial blood pressure of > 50 mm Hg (Fig. 2A). In this model, neuronal death is seen only
in combined CCI plus HS, but not in CCI alone. Without fluid resuscitation of HS survival
is not possible in the combined CCI plus HS insult (Exo et al., 2009). Hextend® was used
since it is the standard resuscitation fluid in combat casualty care. In several animal models,
resuscitation with Hextend® has been shown to require less volume and improve
cerebrovascular function (Crookes et al., 2004; King et al., 2004). PNA is a novel
resuscitation fluid composed of 55 nitroxide moieties covalently linked to albumin that is
administered as a 10% solution. Its stable nitroxyl radicals mimic superoxide dismutase
(SOD) and detoxify reactive oxygen species (Li et al., 2002). We observed that Hextend®
and PNA treated mice displayed significant loss of ascorbate at day 7 after CCI plus HS,
perhaps due to the direct reaction of nitroxides of PNA with ascorbate. There was no
significant loss of ascorbate after mild CCI alone. It is known that recycling of ascorbate
requires reduced glutathione (GSH) (Bradley et al., 1973; Vethanayagam et al., 1999). And,
several studies have shown decreased GSH levels after central nervous system insults,
particularly after severe TBI (Ates et al., 2007; Bayir et al., 2002; Borisenko et al., 2004).
Indeed, in the present study GSH levels were decreased in Hextend® and PNA treated CCI
+ HS groups (Fig. 2B).
The idea of using dual fluorogenic molecules for ascorbate measurements was first proposed
and tested by Lozinsky et al., using TEMPO conjugated with naphthalenesulfonamide
(Lozinsky et al., 1999). Later, dansyl-TEMPO (Likhtenstein et al., 2007) or polymethine-
cyanine-nitroxides (Sato et al., 2009) were employed for the quantitative measurements of
reducing species such as Fe2+ and ascorbic acid. Our previous work has established that AC-
TEMPO effectively reacts with glutathionyl radical (GS•) yielding AC-TEMPO-H
fluorescence (Borisenko et al., 2004). Here we utilized AC-TEMPO as a potentially useful
reagent for the development of a simple and sensitive high-throughput fluorometric method
for analysis of ascorbate in tissues. No other reagents except ascorbate standards and
ascorbate oxidase are necessary. This assay has the ability to measure 96 wells. It is able to
determine AscH− in samples as low as 3.75 μM. A wide variety of samples, be potentially
analyzed with great specificity.
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HPLC high performance liquid chromatography
CCI controlled cortical impact
PNA polynitroxylated albumin
HS hemorrhagic shock
TBI traumatic brain injury
MPA metaphosphoric acid
AO ascorbate oxidase
EPR electron paramagnetic resonance
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Measurement of ascorbate by AC-TEMPO. A – Time-course of AC-TEMPO ESR signal
decay produced by ascorbate (0–46.7 μM). Insert: initial ESR signal. N=3. B – Dose-
dependence of AC-TEMPO ESR signal at 25 min after addition of ascorbate. Insert – Blue:
superposition of Asc• and TEMPO•. Red – simulated spectra. The reaction mixture
contained 100 μM AC-TEMPO. N=3. C – Time-course of accumulation of fluorogenic
product (AC-TEMPO-H) after reaction of AC-TEMPO with ascorbate. Conditions: AC-
TEMPO – 50 μM, ascorbate concentration (in μM) indicated. Note, that after 40 min the
reaction reaches saturation. N=3. D – Typical calibration curve utilized for ascorbate
measurement in biological samples. AC-TEMPO – 20 μM, AscH− 3.75–75 μM (0.5–10 μM
in the well). N=18. E – Calibration curves of freshly prepared ascorbate standards (−MPA)
and standards treated the same way as the tissue samples (+MPA). N=6. F Fluorescence
spectra of AC-TEMPO-H at different pH measured at 30 min. Conditions: AC-TEMPO – 50
μM, ascorbate 10 μM. G –. Specificity of AC-TEMPO assay. Time course of accumulation
of fluorogenic product (AC-TEMPO-H) after reaction of AC-TEMPO with ascorbate in the
presence of dopamine (DA). Conditions: AC-TEMPO – 50 μM, ascorbate – 10 μM, DA (in
μM) as indicated. Note that in the absence of ascorbate, DA did not significantly affect AC-
TEMPO reduction by ascorbate. I –Typical HPLC profile of ascorbate measurement in rat
right cortex (RC). Arrow indicates ascorbate peak in standard and RC sample. Note that
ascorbate peak completely disappears in AO-treated sample.
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A, B – Assessments of ascorbate (A) and GSH (B) loss in murine brain samples after
controlled cortical impact (CCI) and CCI + HS followed by fluid resuscitation with
Hextend® or polynitroxylated albumin (PNA). Significant difference between naïve and
other groups indicated by * (p value < 0.05, N=4–5).
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Table 1
Comparative analysis of ascorbate measurements in rat tissues measured with HPLC and AC-TEMPO.
Sample HPLC AC-TEMPO Predicted value (for spiked sample)
Asc, nmol/mg protein
Liver 1 2.3 ± 0.1 2.6 ± 0.4
Liver 2 2.4 ± 0.1 2.9 ± 0.2
Lung 1 3.9 ± 0.2 4.4 ± 0.1
Lung 2 3.5 ± 0.2 4.4 ± 0.1
Left cortex 33.9 ± 0.1 33.3 ± 4.5
Right cortex 1 31.4 ± 0.4 29.2 ± 3.5
Right cortex 2 26.2 ± 1.6 26.6
Right cortex 3 28.5 ± 0.6 25.8
Right cortex 4 44.8 ± 1.0 42.5
Mean ± SD, N=3
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Table 2
Rates of AC-TEMPO reduction (expressed as pmols per minute ± SD) by ascorbate alone or by ascorbate in
the presence of glutathione (GSH), cysteine,dopamine, urea and bovine serum albumin (BSA) (N = 3–15).

























Urea 3.3 mM −5.21±0.03 24.92±0.92
BSA 3.3 μg/ml 4.58±0.11 32.46±0.11
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Table 3
Assessment of precision of the proposed assay.
Parameter Level 1 (30 μM) Level 2 (40 μM)
Number of runs 25 25
Number of replicates in each run 3 3
Within-Run Imprecision 2.6% 2.0%
Total Imprecision 7.6% 7.1%
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